The low of $2.64 was in April 2012.
The 52-week low is $11.25 according to Yahoo.
The NASDAQ website has the lowest target at $28, and I believe that it is Cowen's.
After all these years, maybe the guys in the lab have developed an encapsulated version of iPlex that slowly releases iGF1 into the bloodstream, mitigating the side effects.
The posters are now accessible on the Insmed website.
There are 3 posters from today's ATS sessions. Early data on INS1009.
On slide 14 of the Investor Presentation, the US launch is in 2017, and the Japan launch in 2018.